Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0C1EO
|
||||
Former ID |
DIB009303
|
||||
Drug Name |
Melanoma vaccine
|
||||
Synonyms |
Melanoma vaccine (ALVAC); Melanoma vaccine (ALVAC), sanofi pasteur; Melanoma vaccine (gp100/MAGE-1/MAGE-3/MART-1/NY-ESO-1, ALVAC), sanofi pasteur
|
||||
Drug Type |
Vaccine
|
||||
Indication | Melanoma [ICD9: 172; ICD10:C43] | Discontinued in Phase 2 | [547218] | ||
Company |
Sanofi Pasteur
|
||||
Target and Pathway | |||||
Target(s) | Melanoma associated antigen 1 | Target Info | [531162] | ||
NY-ESO-1 | Target Info | [531162] | |||
Melanocytes lineage-specific antigen GP100 | Target Info | [531162] | |||
Melanoma-associated antigen 3 | Target Info | [531162] | |||
MART-1 melanoma antigen | Target Info | [531162] | |||
WikiPathways | Notch Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.